Clinical Trials Insight: 700036520

Trial Profile

Clinical Trials Insight: 700036520

Phase of Trial: Phase I

Latest Information Update: 30 Mar 2010

At a glance

  • Drugs NP 61 (Primary)
  • Indications Alzheimer's disease
  • Focus Adverse reactions
  • Sponsors Neuropharm; Noscira
  • Most Recent Events

    • 30 Mar 2010 Status changed from not yet recruiting to completed.
    • 10 Mar 2009 Tolerability results have been reported in a Noscira media release.
    • 22 Aug 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top